Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > THE PASSAGE OF TIME

<< Previous

Bullboard Posts

Next >>

Comment by HIKER2013on Jan 21, 2021 2:17am

175 Views

Post# 32342239

RE: THE PASSAGE OF TIME

Charleyfarley wrote:
Has finally reached its course as we enter a new Era . Our Scientific approach and method of achieving Positive outcomes will finally be honoured with success unprecedented for a small Bio company. Our Formula will be a celebration with unconditional acceptance as the sands of the Hour glass pass before our very eyes.

You sound like a phrophet from the old school.

HR

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario